PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 3 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 7.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $48,955 | +39.3% | 50,000 | 0.0% | 0.00% | – |
Q1 2023 | $35,144 | -19.7% | 50,000 | 0.0% | 0.00% | – |
Q4 2022 | $43,740 | -0.6% | 50,000 | 0.0% | 0.00% | – |
Q3 2022 | $44,000 | +4.8% | 50,000 | 0.0% | 0.00% | – |
Q2 2022 | $42,000 | -4.5% | 50,000 | 0.0% | 0.00% | – |
Q1 2022 | $44,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |